The University-Wide Interdisciplinary Research Center focuses on the involvement of community members, organizations and patients as partners in research and interventions with a mission to prevent disease and improve health for all.

In the face of a bacterium that easily resists common antibiotics, members of UAB established testing to identify it in human disease. Mycoplasma, that is.

UAB researchers report that carriers of specific genetic variants face significantly elevated risks of heart failure, cardiomyopathy and arrhythmia, underscoring the potential benefits of targeted genetic screening.

T-bet expression is required for persistence of memory B cells that have rapid differentiation potential to become antibody-producing plasma cells in response to a second infection.

It is never too late for individuals to take steps to help manage their health as they age.

The finding of TREM2 as a critical regulator of macrophage-mediated fibrosis makes it a promising therapeutic target for intervention for lung fibrotic disease.

Heersink’s thriving start-up culture is producing creative solutions to improve health care outcomes. Academic medical centers (AMCs) are among the United States’ most active hives of biomedical innovation thanks to their often robust research enterprises.

Meet some of Heersink’s outstanding new faculty members. Each issue, we introduce you to several of the exceptional new faculty that have joined the Heersink School of Medicine.

The UAB Medicine Institute for Leadership, the flagship program of the UAB Medicine Leadership Development Office, recently celebrated the graduation of its 10th cohort.

The University of Alabama at Birmingham startup TIXiMED, Inc., has successfully completed a Phase 1 single ascending dose study of the drug TIX100 in humans, marking a key milestone in the development of a first-of-its kind oral therapy for Type 1 diabetes (T1D).

The American Heart Association’s PREVENT CVD risk equation is designed to help predict a person’s risk of a cardiovascular event during their lifetime.

The understanding of how macrophages regulate their response to toxic particles via two independent pathways could uncover therapeutic opportunities to quell inflammation.

An NLP-informed AGI clinic is a viable approach to efficiently improve the systemwide quality of care for patients with AGIs.

Chronic illnesses don’t take Saturdays off, and neither does the team at the UAB O’Neal Comprehensive Cancer Center Infusion Clinic. After experiencing a staggering 44 percent increase in patient encounters since 2020, this 84-bay infusion clinic turned to a dedicated team of multidisciplinary clinicians to pioneer Saturday infusion services.

Twelve UAB employees recently graduated from the Emerging Leaders Series (ELS) spring 2025 leadership development program. The program, presented by the UAB Medicine Leadership Development Office (LDO), recognized its third cohort of graduates at a ceremony on June 5.

Ananda Basu, MBBS, MD, FRCP, M.D., has been appointed as an associate director of the UAB Comprehensive Diabetes Center (UCDC) and will play an integral role on the center’s leadership team.

UAB is a stronghold at finding patients for studies, but healthy controls were harder.

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes, providing tools for further exploration into pancreatic alpha cell function in both Type 1 and 2 diabetes and other metabolic disorders.

The UAB Pancreatobiliary Disease Center (PDC) hosted the second annual Hops & Hope Fair on Saturday, May 31, 2025 at Cahaba Brewing Company.

Congratulations to the 19 faculty and staff leaders who completed UAB’s leadership development program this month. Meet the graduates and see the requirements for the 2025-2026 cohort; nominations open in June.

UAB’s new Lunaphore COMET multiplex immunofluorescent platform can hyperplex up to 40 antibodies on a single pathology tissue sample.

Helping children develop healthy habits at a young age can help lower their risk for heart disease, stroke and other major health problems later in life.

A study published in December 2024 demonstrates how natural language processing techniques, combined with dedicated human personnel, can flag unusual findings in radiology images and connect patients with follow-up care. The work, pioneered in nodules on the adrenal glands, has many applications, the researchers say.

A 3D printer for prosthetics, navigation for patients on dialysis and a new electron microscope are three of the 11 projects to receive funding. The HSF-GEF faculty grants program is a way for UAB to support innovative ideas from its researchers and clinicians.

The 2024 honorees for the President’s Award for Excellence in Teaching represent each school, the College of Arts and Sciences, the Honors College, and the Graduate School.

The Stimulating Access to Research in Residency program, funded by the National Institute of Allergy and Infectious Diseases, is designed to help address the shortage of physician-scientists nationwide.

J. Claude Bennett, M.D., who served as UAB president from 1993 to 1996, passed away on Aug.

The facility, one of 15 shared resource labs at UAB and among the busiest, is one of a handful of leading labs to be recognized by the International Society for Advancement of Cytometry, or ISAC.

Vern Bush, Kevin Davis and Brittany Martin are the first-quarter 2024 honorees of the UAB Values in Action Program. Nominations for second-quarter 2024 honorees are open through April 24.

Carlie Stein Somerville, M.D., an associate professor in the Division of General Internal Medicine, turned an HSF-GEF grant into a nationally recognized program that provides multidisciplinary support to help young adults transition to adult care. Four years later, “we have been able to show the impact that we can make with patients and families,” she said.